288 related articles for article (PubMed ID: 11940059)
1. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors.
Szczeklik A; Sanak M
Clin Exp Allergy; 2002 Mar; 32(3):339-42. PubMed ID: 11940059
[No Abstract] [Full Text] [Related]
2. COX-1 and COX-2 inhibition: current status and future perspective.
Greyn J; Lauwers MH; Vanlersberghe C; Camu F
Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
[No Abstract] [Full Text] [Related]
3. Selective cyclooxygenase-2 inhibitors as potential therapeutic agents for inflammatory diseases.
Chan CC; Rodger IW
Adv Exp Med Biol; 1997; 407():157-61. PubMed ID: 9321947
[No Abstract] [Full Text] [Related]
4. Cyclooxygenase inhibition for postoperative analgesia.
McCrory CR; Lindahl SG
Anesth Analg; 2002 Jul; 95(1):169-76. PubMed ID: 12088963
[No Abstract] [Full Text] [Related]
5. The discovery and function of COX-2.
Needleman P; Isakson PC
J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
[No Abstract] [Full Text] [Related]
6. COX-2 inhibitors: a review.
Houston AM; Teach SJ
Pediatr Emerg Care; 2004 Jun; 20(6):396-9; quiz 400-2. PubMed ID: 15179150
[No Abstract] [Full Text] [Related]
7. Cyclooxygenase-2 inhibitors in aspirin-induced asthma.
Inoue K; Takano H; Kawahito Y; Sano H; Yoshikawa T
Chest; 2003 Apr; 123(4):1317-8; author reply 1318. PubMed ID: 12684334
[No Abstract] [Full Text] [Related]
8. [Specificity, action, indications and safety. Criteria for the use of COX-2 inhibitors].
Wigand R
Pharm Unserer Zeit; 2002; 31(2):190-8. PubMed ID: 11977455
[No Abstract] [Full Text] [Related]
9. Cyclooxygenase-2 inhibitors in aspirin-sensitive asthma.
Passero M; Chowdhry S
Chest; 2003 Jun; 123(6):2155-6; author reply 2156. PubMed ID: 12796206
[No Abstract] [Full Text] [Related]
10. Non-steroidal anti-inflammatory drugs: back to the future.
Flower RJ
Rheumatology (Oxford); 1999 Aug; 38(8):693-6. PubMed ID: 10501413
[No Abstract] [Full Text] [Related]
11. COX-2 inhibition for postoperative analgesia.
McCrory C; E Lindahl SG
Anesth Analg; 2003 Apr; 96(4):1235. PubMed ID: 12651698
[No Abstract] [Full Text] [Related]
12. Alzheimer's disease, cancer and the search for a better aspirin. Postgraduate course at Mount Sinai School of Medicine, New York, NY June 22-23, 2001.
Scriabine A
CNS Drug Rev; 2001; 7(3):346-52. PubMed ID: 11775585
[No Abstract] [Full Text] [Related]
13. [Cyclooxygenases, structure, biological functions and the role in inflammation processes].
Kotyla PJ; Sliwińska-Kotyla B; Kucharz EJ
Pol Arch Med Wewn; 2001 Oct; 106(4):963-6. PubMed ID: 11993417
[No Abstract] [Full Text] [Related]
14. COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.
Whittle BJ
Gut; 2000 Sep; 47(3):320-5. PubMed ID: 10940262
[No Abstract] [Full Text] [Related]
15. The future of NSAID therapy: selective COX-2 inhibitors.
Vane JR; Botting RM
Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
[No Abstract] [Full Text] [Related]
16. Cox-2-selective inhibitors: the new super aspirins.
DeWitt DL
Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
[No Abstract] [Full Text] [Related]
17. Cyclooxygenase inhibition and thrombogenicity.
Catella-Lawson F; Crofford LJ
Am J Med; 2001 Feb; 110 Suppl 3A():28S-32S. PubMed ID: 11173047
[TBL] [Abstract][Full Text] [Related]
18. The promise of coxibs: how far have we progressed?
Schumacher HR
J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S1-4. PubMed ID: 11992742
[No Abstract] [Full Text] [Related]
19. Are COX-2 inhibitors as effective as conventional NSAIDs in acute pain states?
Bannwarth B
Arch Intern Med; 2001 Jan; 161(1):127-8. PubMed ID: 11146712
[No Abstract] [Full Text] [Related]
20. The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition.
Singh-Ranger G; Mokbel K
Eur J Surg Oncol; 2002 Nov; 28(7):729-37. PubMed ID: 12431470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
